NCT03197337

Brief Summary

Small-scale experiments conducted by our group have led to the hypothesis that Localized Provoked Vulvodynia (LPV) may be due to laxity of the Utero-Sacral ligaments (USL). According to this hypothesis, the pain experienced by women with LPV is due to the USL's inability to provide appropriate support for the pudendal nerve. In order to test this hypothesis we will conduct a single-blind randomized control trial in which patients with LPV will undergo a pressure-test - pressure will be temporarily applied to the posterior fornix using a large-sized applicator, thus strengthening the USL and adding support to the pudendal nerve. While the pressure is being applied, the cotton-swab test will be performed (palpating vulvar and vestibular sites using a cotton-swab), and each patient will rate the elicited pain on a scale of 1 to 10 (1 - not painful, 10 - worst pain imaginable). The results for each patient will be compared to their baseline level of pain (which will be recorded in the beginning of the experiment) and to the level of pain they report while inserting a speculum but not applying any pressure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 23, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

July 23, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2018

Completed
Last Updated

October 15, 2019

Status Verified

October 1, 2019

Enrollment Period

7 months

First QC Date

June 22, 2017

Last Update Submit

October 13, 2019

Conditions

Keywords

VulvodyniaLocalized Provoked Vulvodynia (LPV)Referred painUtero-Sacral ligaments laxity

Outcome Measures

Primary Outcomes (1)

  • Level of pain

    Patients will rate the level of pain elicited each time the cotton-swab test will be performed, using a 1-10 scale (1 - not painful, 10 - worst pain imaginable).

    Immediate result

Study Arms (2)

Control manipulation first

EXPERIMENTAL

Patients in this group will first undergo the control manipulation while the study manipulation will follow.

Procedure: Pressure-test

Study manipulation First

EXPERIMENTAL

Patients in this group will first undergo the study manipulation while the control manipulation will follow.

Procedure: Pressure-test

Interventions

Pressure-testPROCEDURE

Pressure will be applied to the posterior fornix using a speculum.

Control manipulation firstStudy manipulation First

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women who suffer from LPV that are otherwise healthy.
  • Symptoms severity in each patient is either moderate (able to engage in sexual intercourse despite suffering immense pain) or severe (unable to engage in sexual intercourse due to unbearable pain).
  • Patients who have signed an informed consent form.

You may not qualify if:

  • Women who suffer from Generalized Vulvodynia.
  • Women who previously received other treatments for LPV, including but not limited to surgery, neuropathic treatment and/or physiotherapy.
  • Women with uterine prolapse.
  • Women who present with genito-urinary infection/inflammation at the day of the trial, or have healed from such a condition less then 14 days prior to the day of the trial.
  • Women who have previously participated in clinical trials under which they received treatment for Vulvodynia.
  • Women with LPV whose symptoms severity is defined as light (able to engage in sexual intercourse while suffering light pain / discomfort).
  • Women who are pregnant at the day of the trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Obstetrics and Gynecology

Nahariya, Israel

Location

Related Publications (4)

  • Petros P, Bornstein J. Re: vulvar vestibulitis may be a referred pain arising from laxity in the uterosacral ligaments: a hypothesis based on three prospective case reports. Aust N Z J Obstet Gynaecol. 2004 Oct;44(5):484-5. doi: 10.1111/j.1479-828X.2004.00297.x. No abstract available.

    PMID: 15387884BACKGROUND
  • Bornstein J, Zarfati D, Petros P. Re: Causation of vulvar vestibulitis. Aust N Z J Obstet Gynaecol. 2005 Dec;45(6):538-9. doi: 10.1111/j.1479-828X.2005.00499.x. No abstract available.

    PMID: 16401228BACKGROUND
  • Friedrich EG Jr. Vulvar vestibulitis syndrome. J Reprod Med. 1987 Feb;32(2):110-4.

    PMID: 3560069BACKGROUND
  • Bornstein J, Goldstein AT, Stockdale CK, Bergeron S, Pukall C, Zolnoun D, Coady D; consensus vulvar pain terminology committee of the International Society for the Study of Vulvovaginal Disease (ISSVD); International Society for the Study of Women's Sexual Health (ISSWSH); International Pelvic Pain Society (IPPS). 2015 ISSVD, ISSWSH, and IPPS Consensus Terminology and Classification of Persistent Vulvar Pain and Vulvodynia. J Sex Med. 2016 Apr;13(4):607-12. doi: 10.1016/j.jsxm.2016.02.167. Epub 2016 Mar 25.

    PMID: 27045260BACKGROUND

MeSH Terms

Conditions

VulvodyniaPain, Referred

Condition Hierarchy (Ancestors)

Vulvar DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jacob Bornstein, Prof

    Chair, Obstetrics and Gynecology department

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participants will not be informed prior to the experiment if they will first undergo the control manipulation or the study manipulation.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chairman, Department of Obstetrics & Gynecology

Study Record Dates

First Submitted

June 22, 2017

First Posted

June 23, 2017

Study Start

July 23, 2017

Primary Completion

March 2, 2018

Study Completion

March 2, 2018

Last Updated

October 15, 2019

Record last verified: 2019-10

Locations